Opko Health, Inc.
OPK- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000944809
No open-market purchases or sales by Opko Health, Inc. insiders were filed in the last 90 days; 225 institutions reported holding it in 13F filings for Q2 2026, worth $368.6M in total; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, −9 vs. previous quarter
- 225
- 13F valueReported value at the end of Q2 2026
- $368.6M
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding OPK, Q2 2026
No superinvestor reported holding OPK at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Opko Health, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 20, 2026 (view filing) | Mar 20 | Same day | Paganelli John ADirector | PPurchase | +10.0K | $1.14 | +$11.4K | +2.6%394.3K after | |
| Nov 21, 2025 (view filing)5:07 PM ET | Nov 21 | Same day | Frost Phillip MD Et Al and 1 otherCEO & Chairman | PPurchase | +580.0K | $1.33 | +$768.8K | +0.3%216.7M after | 5 lots |
| Nov 20, 2025 (view filing)6:10 PM ET | Nov 20 | Same day | Frost Phillip MD Et Al and 1 otherCEO & Chairman | PPurchase | +580.0K | $1.33 | +$771.3K | +0.3%216.1M after | 7 lots |
| Nov 19, 2025 (view filing)5:02 PM ET | Nov 19 | Same day | Frost Phillip MD Et Al and 1 otherCEO & Chairman | PPurchase | +580.0K | $1.31 | +$759.1K | +0.3%215.5M after | 9 lots |
| Nov 18, 2025 (view filing)5:18 PM ET | Nov 18 | Same day | Frost Phillip MD Et Al and 1 otherCEO & Chairman | PPurchase | +533.3K | $1.27 | +$678.9K | +0.2%215.0M after | 11 lots |
| Oct 31, 2025 (view filing)5:15 PM ET | Oct 31 | Same day | Frost Phillip MD Et Al and 1 otherCEO & Chairman | PPurchase | +150.0K | $1.42 | +$213.4K | +0.1%214.4M after | |
| Aug 8, 2025 (view filing)4:56 PM ET | Aug 8 | Same day | Frost Phillip MD Et Al and 1 otherCEO & Chairman | PPurchase | +675.0K | $1.32 | +$891.0K | +0.3%214.7M after | |
| Apr 10, 2025 (view filing)5:07 PM ET | Apr 10 | Same day | Frost Phillip MD Et Al and 1 otherCEO & Chairman | PPurchase | +125.0K | $1.36 | +$169.7K | +0.1%214.0M after | |
| Apr 8, 2025 (view filing)5:34 PM ET | Apr 8 | Same day | Frost Phillip MD Et Al and 1 otherCEO & Chairman | PPurchase | +125.0K | $1.48 | +$184.7K | +0.1%213.9M after | |
| Apr 1, 2025 (view filing)5:21 PM ET | Apr 1 | Same day | Frost Phillip MD Et Al and 1 otherCEO & Chairman | PPurchase | +100.0K | $1.65 | +$164.8K | 0.0%213.8M after |
Top 10 13F holders, Q2 2026
The largest institutional positions in Opko Health, Inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Rubric Capital Management LP | 47,791,243 | $73.6M | 0.67% | 00.0% | Unchanged |
| BlackRock, Inc. | 36,978,893 | $55.5M | 0.00% | +746,670+2.1% | Added |
| Vanguard Capital Management LLC | 14,968,930 | $22.5M | 0.00% | +469,766+3.2% | Added |
| Vanguard Portfolio Management LLC | 14,934,924 | $22.4M | 0.00% | +165,205+1.1% | Added |
| Whitefort Capital Management, LP | 4,511,412 | $20.8M | 5.14% | +258,072+6.1% | Added |
| Wolverine Asset Management LLC | – | $20.4M | 0.27% | – | – |
| Geode Capital Management, LLC | 11,581,027 | $17.4M | 0.00% | +279,526+2.5% | Added |
| State Street Corp | 10,309,070 | $15.5M | 0.00% | +807,693+8.5% | Added |
| PenderFund Capital Management Ltd. | – | $12.8M | 1.64% | – | – |
| Goldman Sachs Group Inc | 7,035,492 | $10.6M | 0.00% | −639,534−8.3% | Reduced |